| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $689,648 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 6 | 5/31/2024 | NON-COMPETING CONTINUATION | $689,648 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 5 | 6/2/2023 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $689,648 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 5 | 7/14/2022 | NON-COMPETING CONTINUATION | $666,480 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 006 | 5 | 9/27/2022 | NON-COMPETING CONTINUATION | $85,050 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 5 | 8/17/2022 | NON-COMPETING CONTINUATION | $23,168 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 4 | 5/27/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $689,647 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 3 | 9/27/2022 | NON-COMPETING CONTINUATION | -$1 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 5/27/2022 | NON-COMPETING CONTINUATION | -$689,647 |
| 2022 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 2 | 9/27/2022 | NON-COMPETING CONTINUATION | -$85,049 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $689,648 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 3 | 6/16/2021 | NON-COMPETING CONTINUATION | $0 |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 6/1/2021 | NON-COMPETING CONTINUATION | $689,648 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $710,049 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 2 | 5/5/2020 | NON-COMPETING CONTINUATION | $710,049 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $632,498 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 5/30/2019 | NEW | $632,498 |
|
|